Aptimmune Biologics

Innovating swine mucosal vaccines for disease protection and improved animal health

placeChampaign, Illinois, United States calendar_todayFounded 2010 groups3 employees language aptimmune.com

Registered entities

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 44 times.

YearFilings
20171
20181
20191
20201
20211
20221
20231

Investor mix

10 investors on record; lead investors include Arsenal Capital Partners, Fox Ventures, St. Louis Arch Angels, Missouri Technology.

Investor typeCountShare
Venture capital770%
Private equity110%
Angel & family office110%
Other / undisclosed110%
Coming soon